Pfizer has signed an agreement with the United Nations-backed Medicines Patent Pool to license its new experimental Covid-19 pill to generic companies that can supply it to 95 low- and middle-income countries. The move is similar to what Merck has done previously.

https://www.zerohedge.com/markets/pfizer-locks-global-distribution-its-covid-pill-promising-royalty-free-sales-95-low-and

 

OF course it will……….that’s what happens when a single purpose drug competes with a multi-purpose drug that’s already available @ $.04/pill (or less)……..